We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chinese API Manufacturer Gets Warning Letter
Chinese API Manufacturer Gets Warning Letter
February 2, 2009
Shaanxi Hanjiang Pharmaceutical was cited by the FDA in a warning letter for GMP violations involving production of active pharmaceutical ingredients (API) for human and animal use.